NCT01016782View on ClinicalTrials.gov

Study of 0444 Gel in the Treatment of Inflammatory Lesions of Rosacea

PHASE3CompletedINTERVENTIONAL
Enrollment

867

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Inflammatory Rosacea
Interventions
DRUG

0444

A thin film of gel will be applied and rubbed into the entire face once daily for a period of 70 days

Sponsors
All Listed Sponsors
lead

Fougera Pharmaceuticals Inc.

INDUSTRY

NCT01016782 - Study of 0444 Gel in the Treatment of Inflammatory Lesions of Rosacea | Biotech Hunter | Biotech Hunter